Trials / Recruiting
RecruitingNCT07345169
IMMUNOREA - Immunological and Inflammatory Determinants Associated With the Prognosis of Intensive Care Patients
Studies on the Immunological and Inflammatory Determinants Associated With the Prognosis of Patients Admitted to Intensive Care
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 540 (estimated)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective observational physiopathological study aimed at evaluating the immunological and inflammatory determinants associated with the prognosis of patients admitted to intensive care units (ICU). The study will establish multidimensional models predicting one-year survival and the occurrence of nosocomial infections. Patients admitted to ICU undergo routine biological sampling. In addition to these, minimal supplementary samples will be collected for immunological and inflammatory biomarker analysis at admission, day 1, day 4, day 8, ICU discharge or day 28, and at 12 months. Additional samples may be taken during clinically significant events (nosocomial infections, complications).
Conditions
- Critical Illness
- Intensive Care Patients
- Critical Illness Requiring Intensive Care - Sepsis
- Critical Illness Requiring Intensive Care - Acute Brain Injury
- Critical Illness Requiring Intensive Care - Major Surgery
- Critical Illness Requiring Intensive Care - Polytrauma
Timeline
- Start date
- 2026-01-01
- Primary completion
- 2031-02-01
- Completion
- 2031-02-01
- First posted
- 2026-01-15
- Last updated
- 2026-01-15
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07345169. Inclusion in this directory is not an endorsement.